Varicose Veins Treatment Market Size, Share and Trends 2026 to 2035
Varicose Veins Treatment Market (By Type: Endovenous Ablation, Endovenous Laser Therapy, Radiofrequency Ablation, Injection Sclerotherapy, Surgical Ligation & Stripping; By End-Use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035
Get a Sample
Table Of Content
What is the Varicose Veins Treatment Market Size in 2026?
The global varicose veins treatment market size accounted for USD 1.59 billion in 2025 and is predicted to increase from USD 1.69 billion in 2026 to approximately USD 2.96 billion by 2035, expanding at a CAGR of 6.44% from 2026 to 2035. This market is growing due to rising cases of venous disorders and increasing demand for minimally invasive treatments.
Key Takeaways
- North America dominated the global varicose veins treatment market in 2025.
- Asia Pacific is expected to grow at the fastest CAGR between 2026 and 2035.
- By type, the injection sclerotherapy segment held the biggest market share in 2025.
- By type, the endovenous ablation segment is expected to expand at the fastest CAGR between 2026 and 2035.
- By end user, the hospitals segment contributed the highest market share in 2025.
- By end user, the ambulatory surgical centers segment is expected to grow at a strong CAGR between 2026 and 2035.
Why is the Varicose Veins Treatment Market Gaining Momentum?
The varicose veins treatment market is expanding steadily because chronic venous diseases are becoming more common, particularly in the elderly and those who lead sedentary lifestyles. Patient preference for efficient and less painful treatments is being driven by growing awareness of early diagnosis and the availability of minimally invasive procedures like sclerotherapy, laser therapy, and radiofrequency ablation. These operations are also becoming more accessible due to improvements in healthcare infrastructure and medical technology, which is fostering steady market expansion in both developed and developing nations.
The demand for varicose veins treatment is increasing due to the rising incidence of venous disorders and growing preference for minimally invasive procedures. Treatments are increasingly performed in outpatient settings, helping providers maintain high patient volumes and profitability while reducing operating costs. Continuous technological advancements enable faster recovery and cost-effective care, attracting more patients. Additionally, expanding insurance coverage and growing aesthetic awareness are supporting steady revenue growth, making the market attractive to both healthcare providers and investors.
How is Artificial Intelligence Transforming the Varicose Veins Treatment Market?
Artificial Intelligence is reshaping the varicose veins treatment market through better treatment planning and increased diagnostic precision. AI-enabled imaging technologies can assess the structure of veins, identify the severity of disease, and help doctors choose the best minimally invasive procedures. Additionally, predictive analytics aids in identifying patients who are more likely to develop chronic venous insufficiency, allowing for earlier intervention. AI integration is enhancing clinical outcomes and opening up new growth opportunities for cutting-edge treatment solutions as healthcare facilities embrace data-driven and intelligent technologies.
Major Market Trends
- Growing Adoption of Minimally Invasive Procedures: Patients increasingly prefer laser ablation, radiofrequency ablation, and sclerotherapy due to shorter recovery times.
- Rising Cosmetic Consciousness: Demand for aesthetic improvement is encouraging early treatment of visible varicose veins.
- Technological Advancement in Devices: Advanced imaging and catheter-based systems are improving procedural accuracy and outcomes.
- Increases in Outpatient Treatments: Many procedures are shifting to ambulatory surgical centers, reducing costs and hospital stays.
- Aging Population Growth: Elderly individuals are more prone to venous insufficiency, supporting sustained market demand.
- Sedentary Lifestyle Impact: Long working hours and limited physical activity are increasing the prevalence of venous disorders.
- Improved Awareness and Diagnosis: Health campaigns and better screening tools are leading to earlier detection.
- Insurance Coverage Expansion: Broader reimbursement policies are making treatments more accessible to patients.
Future Market Outlook
- Untapped Emerging Economies: Expanding healthcare access in developing regions creates new patient pools.
- Development of Non-Thermal Technologies: Innovative non-invasive and non-thermal techniques offer safer treatment alternatives.
- Product Innovation with Better Patient Comfort: Devices designed for reduced pain and faster recovery can gain a competitive advantage.
- Expansion of Specialty vein Clinics: Growth of dedicated vascular clinics increases treatment volumes.
- Integration with Digital Health Platforms: Telemedicine and remote consultations can improve early diagnosis and patient engagement.
- Strategic with Digital Health Platforms: Alliances between device manufacturers and healthcare providers enhance distribution reach.
- Rising Medical Tourism: Affordable treatment options in certain countries attract international patients.
- Focus on Preventive Care Programs: Awareness initiatives promoting early intervention create long-term market growth opportunities.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 1.59 Billion |
| Market Size in 2026 | USD 1.69 Billion |
| Market Size by 2035 | USD 2.96 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 6.44% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Type, End-Use, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Government Initiatives Supporting the Varicose Veins Treatment Market
| Country/Region | Government Programs | Initiatives Focus | Impact on Market Growth |
| U.S. | Centers for Medicare & Medicaid Services (CMS) | Reimbursement policies for medically necessary vein procedures | Expands patient access to minimally invasive treatments, increasing procedure volumes. |
| U.S. | National Institute of Health (NIH) | Funding for vascular disease research | Encourages innovation in advanced vein treatment technologies and devices |
| India | Ayushman Bharat | Coverage for surgical and vascular procedures | Improves the affordability of vein treatment in public and empaneled private hospitals |
| India | National Health Mission | Strengthening secondary and tertiary healthcare services | Enhances vascular care infrastructure, supporting higher treatment adoption. |
| EU | EU Medical Device Regulation (MDR) | Strict quality and safety standards for medical devices | Promotes adoption of certified, high-quality vein treatment devices across Europe. |
| China | National Health Commission of the People's Republic of China | Public hospital upgrades and vascular care programs | Expands surgical capacity and improves access to modern vein treatments. |
| UK | National Health Service (NHS) | Guidelines for chronic venous disease management | Standardizes treatment pathways and supports reimbursement for eligible cases. |
| Global | World Health Organization (WHO) | Non-communicable disease (NCD) control programs |
Raise awareness of vascular disorders and promote early diagnosis and care access. |
Segment Insights
Type Insights
What Made Injection Sclerotherapy the Dominant Segment in the Varicose Veins Treatment Market?
The injection sclerotherapy segment dominated the market while holding the largest share in 2025 because it is affordable, suitable for small to medium sized varicos veins, and minimally invasive. The procedure is performed in outpatient settings, requires no major surgery, and offers quick recovery times. Its dominance is further supported by rising patient awareness of early vein treatment and a strong preference for non-surgical solutions.
The endovenous ablation segment is expected to grow at the fastest CAGR in the coming years due to its long-term efficacy and high success rate. More rapid recovery and less pain are possible with precise vein closure thanks to advanced laser and radiofrequency technologies. Growing demand for long-lasting treatment results and growing adoption of technologically sophisticated procedures are fueling segment expansion. Adoption is also being accelerated by a growing physician preference for image-guided techniques. Another factor driving rapid expansion is growing patient awareness of advanced options and ongoing technological advancements.
End Use Insights
Why Did the Hospitals Segment Dominate the Varicose Veins Treatment Market?
The hospitals segment dominated the market with the largest share in 2025 because highly qualified vascular specialists and state-of-the-art treatment infrastructure are available in these facilities. Hospitals provide thorough diagnostic and post-procedure care for patients with complex varicose veins. Additionally, insurance coverage for hospital-based treatments also reinforced the segment's dominance. Multidisciplinary teams make it possible to manage severe venous conditions effectively. Hospitals are more prepared to manage complications, which boosts treatment volume and patient confidence.
The ambulatory surgical centers segment is expected to grow at the fastest CAGR in the coming years because waiting times and shorter treatment costs are lower. With quicker discharge times and individualized treatment, ASCs offer effective outpatient procedures. The market is expanding more quickly due to consumers' growing desire for convenient, minimally invasive procedures. Patient inflow is being further stimulated by better reimbursement support for outpatient procedures. ASCs' streamlined operational models also contribute to lower overall healthcare costs, which increases their appeal.
Regional Insights
Why Did North America Dominate the Varicose Veins Treatment Market?
North America dominated the market by holding a major share in 2025 because of the heightened adoption of cutting-edge vein treatment technologies, robust healthcare infrastructure, and high levels of awareness. Regional market growth is further bolstered by favorable reimbursement policies and a sizable aging population that is susceptible to venous disorders. Higher treatment volumes were a result of proactive healthcare-seeking behavior and early diagnosis rates. Additionally, regional dominance in the market is strengthened by the presence of well-established market players and ongoing product innovation.
U.S. Varicose Veins Treatment Market Trends
The market in the U.S. is expanding as a result of rising demand for minimally invasive procedures such as laser ablation and schlerotherapy. Increasing awareness about aesthetics and early diagnosis of chronic venous insufficiency are boosting procedural volumes. Technological innovations and the strong presence of key players continue to strengthen the country's position. Growing outpatient treatment adoption and insurance coverage expansion are further driving growth. Increasing awareness campaigns about vein health are also supporting early intervention trends.
What Makes Asia Pacific the Fastest-Growing Region in the Market?
Asia Pacific is expected to grow at the fastest CAGR in the coming years because of growing patient awareness and better healthcare infrastructure. The market is growing thanks to rising medical tourism and growing networks of private hospitals. Access to cutting-edge treatments is improving due to urbanization and rising disposable income. Regional development is being further accelerated by government initiatives to improve vascular care services.
India Varicose Veins Treatment Market Trends
Advanced vein treatment technologies are gaining popularity in India, driven by the rising prevalence of lifestyle-related venous disorders and improved access to specialized vascular care. Growing awareness campaigns and enhanced affordability are further supporting market expansion. The rise of private hospitals and specialty clinics is improving treatment accessibility, while medical tourism and cost-effective procedures are attracting both domestic and international patients.
How is the Opportunistic Rise of Europe in the Market?
Europe held a substantial share of the varicose veins treatment market in 2025 and is expected to grow at a steady rate in the coming years. This is because of its well-developed healthcare systems and increasing incidence of venous disorders. Strong reimbursement structures and the early uptake of minimally invasive treatments like sclerotherapy and laser ablation are advantageous to the area. The market is further driven by an aging population and an increase in the prevalence of chronic venous insufficiency. Furthermore, the existence of highly qualified vascular specialists and state-of-the-art medical facilities supported regional expansion.
Germany Varicose Veins Treatment Market Trends
Germany is one of the major contributors to the European market because of its state-of-the-art medical facilities and emphasis on medical innovation. Because of the country's advantageous reimbursement policies, endovenous ablation procedures are widely used. The number of procedures is rising due to growing awareness of early diagnosis and preventive vein care. Furthermore, minimally invasive treatments are being promoted by Germany's robust outpatient care network. The demand for cosmetic vein correction procedures and an aging population are driving the market's expansion.
Varicose Veins Treatment Market Value Chain Analysis
Varicose Veins Treatment Market Companies
- Medtronic
- Lumenis Be Ltd.
- AngioDynamics
- Sciton
- Quanta System
- Intros Medical Laser GmbH
- Alma lasers
- Dornier MedTech
- Theraclion
Recent Developments
- In February 2026, InVera Medical announced European CE Mark approval for its novel InVera Infusion Device. This non-thermal, minimally invasive technology was launched to treat diseased leg veins in office-based settings without requiring tumescent anesthesia. The device is designed to improve patient experience by eliminating the heat-based risks associated with traditional varicose vein procedures.(Source: https://www.prnewswire.com/)
- In February 2025, Aakash Healthcare and Medtronic announced the launch of North India's first specialized vein clinic in New Delhi. The facility provides a comprehensive one-stop solution for advanced diagnosis and minimally invasive treatments for varicose veins. This collaboration leverages Medtronic's technologies to offer patients faster recovery and improved clinical outcomes.(Source: https://ehealth.eletsonline.com)
Segments Covered in the Report
By Type
- Endovenous Ablation
- Endovenous Laser Therapy
- Radiofrequency Ablation
- Injection Sclerotherapy
- Surgical Ligation & Stripping
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting